Pharma-Bio Serv (PBSV) Capital Expenditures Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -70.37% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | -64.78% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 18,423.26% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -93.77% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 49.50% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 182.47% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 1,174.08% |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -45.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -45.49% |
| Oct 31, 2025 | -99.78% |
| Jul 31, 2025 | 6.71% |
| Oct 31, 2024 | 10,037.66% |
| Jan 31, 2024 | -89.84% |
| Oct 31, 2023 | -113.02% |
| Apr 30, 2023 | -82.48% |
| Jan 31, 2023 | 1,079.39% |
| Oct 31, 2022 | 1,477.64% |
| Jul 31, 2022 | -70.65% |
| Apr 30, 2022 | 112.94% |
| Jan 31, 2022 | -73.36% |
| Oct 31, 2021 | -113.94% |
| Jul 31, 2021 | -32.04% |
| Apr 30, 2021 | -92.57% |
| Jan 31, 2021 | -77.33% |
| Oct 31, 2020 | -30.79% |
| Jul 31, 2020 | 11.27% |
| Apr 30, 2020 | -22.97% |
| Jan 31, 2020 | 267.37% |